The King Returns - Novavax soars 18%! Vaxart runs up 12% and Sorrento breaks out over 10%.
There were 19 winners and 7 losers. The overall average was a very strong gain of 3.3%.
Other strong performers were Inovio and Vir at 7%. BioNTech, VBI and Cure Vac all gained 6%. Finally, Altimmune gained over 5%.
The only loser that fell beyond 5% is Onco Sec.
No comments:
Post a Comment